During the past decade, Ospedale Civile SS. Annunziata conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Civile SS. Annunziata" #1 sponsor was "Gilead Sciences" with 2 trials, followed by "IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy" with 2 trials sponsored, "Mario Negri Institute for Pharmacological Research" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Casa Sollievo della Sofferenza IRCCS" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Civile SS. Annunziata" #1 collaborator was "Clinical Research Technology S.r.l." with 2 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator, "F.A.V.O. Italian Federation of Volunteer-Based Cancer Organizations" with 1 trials as a collaborator, "IRCCS AOU San Martino -IST Genoa" with 1 trials as a collaborator and "IRCCS Policlinico S. Matteo" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Civile SS. Annunziata" are "Acute Myocardial Infarction" (1 trials), "Angina Pectoris" (1 trials), "Anticoagulant Drugs" (1 trials), "Aortic Dissection" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Ospedale Civile SS. Annunziata" in a lesser frequency.

Most popular intervention types in "Ospedale Civile SS. Annunziata" are "Drug" (12 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ARA-C" (1 trials), "ASCT" (1 trials), "Adalimumab" (1 trials), "Anastrozole or Letrozole or Exemestane" (1 trials) and "BCNU" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Civile SS. Annunziata" are 17 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Civile SS. Annunziata". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Ospedale Civile SS. Annunziata, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Civile SS. Annunziata, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".